Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05469477 · ClinicalTrials.gov registry record · NA

Increasing Seat Belt Wearing and Decreasing Handheld Phone Use While Driving

A NA study of Impaired Driving and Distracted Driving, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
1,139
Enrollment target
1
Study location

NCT05469477: Completed NA study of Impaired Driving and Distracted Driving, sponsored by University of Pennsylvania.

NCT05469477 is a NA study of Impaired Driving and Distracted Driving that has completed, run by University of Pennsylvania. The registered enrollment target is 1,139 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05469477, a NA study of Impaired Driving and Distracted Driving, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
1,139 participants
Enrollment target
1
Study location

Study Summary

The study team is proposing to conduct a randomized controlled trial to determine the effectiveness of behavioral and financial incentives on phone use while driving and seat belt adherence. Each arm will receive a support text if their app is not collecting data. The behavioral engagement intervention includes persuasive education, mental contrasting with implementation intentions, customized habit tips, weekly feedback about participants' streaks, and encouraging SMS texts. The two financial incentive interventions add on weekly raffles or shared pots for participants with perfect streaks.

Primary Outcome

Calculated as the number of trips during which a driver's seat belt click was detected, divided by total number of trips (defined as 1/10 of a mile or greater).

Interventions

  • BEHAVIORAL Persuasive education
  • BEHAVIORAL WOOP (aka, mental contrasting with implementation intentions., Wish, Outcome, Obstacle, Plan)
  • BEHAVIORAL Customized Habit Tips
  • BEHAVIORAL Raffle Financial Incentive
  • BEHAVIORAL Shared Pot Financial Incentive

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,139 participants
Start Date 2023-03-12
Est. Completion 2023-06-29
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05469477 record still lists

NCT05469477 is an interventional study that assigns participants to a tested intervention. Its 1,139 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower).

The record links to 3 conditions, with Impaired Driving appearing as the primary indexed condition, and to 5 interventions - of which Persuasive education is the first listed.

NCT05469477 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05469477 about?

NCT05469477 is a clinical study titled "Increasing Seat Belt Wearing and Decreasing Handheld Phone Use While Driving". The study team is proposing to conduct a randomized controlled trial to determine the effectiveness of behavioral and financial incentives on phone use while driving and seat belt adherence. Each arm will receive a support text if their app is not collecting data. The behavioral engagement intervent...

What is the current status of trial NCT05469477?

This trial is currently completed. It is a NA study. The enrollment target is 1,139 participants. The study started on 2023-03-12. Estimated completion is 2023-06-29.

What conditions does trial NCT05469477 study?

This clinical trial studies the following conditions: Impaired Driving, Distracted Driving, Driving Behaviors.

What interventions are being tested in trial NCT05469477?

The interventions under investigation include: Persuasive education (BEHAVIORAL), WOOP (aka, mental contrasting with implementation intentions., Wish, Outcome, Obstacle, Plan) (BEHAVIORAL), Customized Habit Tips (BEHAVIORAL), Raffle Financial Incentive (BEHAVIORAL), Shared Pot Financial Incentive (BEHAVIORAL).

Who is sponsoring clinical trial NCT05469477?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05469477 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Impaired Driving

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05469477's enrollment target sits among peer trials

1,139 93rd of 2000 higher than 1,908 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05894967 · 1,140 participants · NA

    Moderators and Mediators of Perceptual Learning

  • NCT06532487 · 1,140 participants · NA

    Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities

  • NCT06129864 · 1,145 participants · Phase 3

    A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

  • NCT06676319 · 1,147 participants · Phase 2

    Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05469477, the US trial registry maintained by the National Library of Medicine. NCT05469477 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.